Victory Capital Management
TIL icon

Victory Capital Management’s Instil Bio TIL Stock Holding History

Victory Capital Management’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-967
Closed -$94K – 2703
2022
Q3 		$94K Sell
967
-65
-6% -$7.43K ﹤0.01% 2485
2022
Q2 		$95K Sell
1,032
-1
-0.1% -$142 ﹤0.01% 2465
2022
Q1 		$146K Sell
1,033
-22
-2% -$5.14K ﹤0.01% 2461
2021
Q4 		$361K Sell
1,055
-55
-5% -$21.2K ﹤0.01% 2320
2021
Q3 		$397K Buy
1,110
+264
+31% +$98.6K ﹤0.01% 2287
2021
Q2 		$327K Buy
846
+96
+13% +$35.6K ﹤0.01% 2388
2021
Q1 		$376K Buy
+750
New +$385K ﹤0.01% 2328

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management's TIL Position: Q4 2022 in Review

Victory Capital Management sold out of Instil Bio (TIL) in Q4 2022, closing a stake of 967 shares — an estimated $94K sold.

Victory Capital Management first reported a position in TIL in Q1 2021 and held it in 7 quarters. The position peaked at $397K in Q3 2021. 78 funds tracked by Wall St. Rank hold TIL as of Q4 2022.

  • Victory Capital Management reported no remaining Instil Bio position as of Q4 2022 after selling out during the quarter.
  • Victory Capital Management sold 967 Instil Bio shares in Q4 2022, an estimated $94K.
  • Victory Capital Management first reported a position in Instil Bio in Q1 2021 and held it in 7 quarters.
  • Victory Capital Management's Instil Bio position peaked at $397K in Q3 2021.
  • 78 funds tracked by Wall St. Rank held Instil Bio as of Q4 2022.

Based on Victory Capital Management's 13F filing for Q4 2022, filed 9 Feb 2023.